Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids

Journal of Internal Medicine

Volumn 280, Issue 5, 2016, Pages 465-475

  Smith, U ^a   Kahn, B B ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adipose tissue; glucose; insulin resistance; lipogenesis; type 2 diabetes

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; GLUCOSE TRANSPORTER 4; HYDROXY FATTY ACID; LIPID; OSTEOGENIC PROTEIN 1; ESTER; FATTY ACID;

ADIPOGENESIS; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY FAT; CELL DIFFERENTIATION; CELL PROLIFERATION; FAMILY HISTORY; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIPOGENESIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE; ADIPOCYTE; BODY MASS; CYTOLOGY; ETHNOLOGY; LIPID METABOLISM; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; SUBCUTANEOUS FAT;

ADIPOCYTES; ADIPOGENESIS; BODY MASS INDEX; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; ESTERS; FATTY ACIDS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; OBESITY; SUBCUTANEOUS FAT;

EID: 84990235740     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12540     Document Type: Article

References (53)

1. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015.
2. Li R, Lu W, Jia J et al. Relationships between indices of obesity and its cardiovascular comorbidities in a Chinese population. Circ J 2008; 72: 973–8.
3. The IDF consensus worldwide definition of the metabolic syndrome. Brussels, Belgium: International Diabetes Federation, 2005; April 14. http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf
4. Perry RJ, Camporez JP, Kursawe R et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell 2015; 160: 745–58.
5. Arner P, Langin D. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends Endocrinol Metab 2014; 25: 255–62.
6. Graham TE, Yang Q, Bluher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552–63.
7. Carvalho E, Jansson PA, Nagaev I, Wenthzel AM, Smith U. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J 2001; 15: 1101–3.
8. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150–62.
9. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–7.
10. Nakamura T, Tokunaga K, Shimomura I et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107: 239–46.
11. McNeely MJ, Shofer JB, Leonetti DL, Fujimoto WY, Boyko EJ. Associations among visceral fat, all-cause mortality, and obesity-related mortality in Japanese Americans. Diabetes Care 2012; 35: 296–8.
12. Gustafson B, Smith U. Regulation of white adipogenesis and its relation to ectopic fat accumulation and cardiovascular risk. Atherosclerosis 2015; 241: 27–35.
13. Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation 2015; 132: 1639–47.
14. Neeland IJ, Turer AT, Ayers CR et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012; 308: 1150–9.
15. Lonn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 2010; 24: 326–31.
16. Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes 2009; 58: 1550–7.
17. Spalding KL, Arner E, Westermark PO et al. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783–7.
18. Arner E, Westermark PO, Spalding KL et al. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes 2010; 59: 105–9.
19. Gustafson B, Smith U. The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 2012; 61: 1217–24.
20. Bowers RR, Kim JW, Otto TC, Lane MD. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci USA 2006; 103: 13022–7.
21. Gustafson B, Hammarstedt A, Hedjazifar S et al. BMP4 and BMP antagonists regulate human white and beige adipogenesis. Diabetes 2015; 64: 1670–81.
22. Ryden M, Uzunel M, Hard JL et al. Transplanted bone marrow-derived cells contribute to human adipogenesis. Cell Metab 2015; 22: 408–17.
23. InterAct C, Langenberg C, Sharp SJ et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med 2012; 9: e1001230.
24. Cederberg H, Stancakova A, Kuusisto J, Laakso M, Smith U. Family history of type 2 diabetes increases the risk of both obesity and its complications: is type 2 diabetes a disease of inappropriate lipid storage? J Intern Med 2015; 277: 540–51.
25. Arner P, Arner E, Hammarstedt A, Smith U. Genetic predisposition for type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS One 2011; 6: e18284.
26. Acosta JR, Douagi I, Andersson DP et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia 2016; 59: 560–70.
27. Nusse R. Wnt signaling and stem cell control. Cell Res 2008; 18: 523–7.
28. Hammarstedt A, Hedjazifar S, Jenndahl L et al. WISP2 regulates preadipocyte commitment and PPARgamma activation by BMP4. Proc Natl Acad Sci USA 2013; 110: 2563–8.
29. Soccio RE, Chen ER, Lazar MA. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab 2014; 20: 573–91.
30. Qian SW, Tang Y, Li X et al. BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc Natl Acad Sci USA 2013; 110: E798–807.
31. Sidossis LS, Porter C, Saraf MK et al. Browning of subcutaneous white adipose tissue in humans after severe adrenergic stress. Cell Metab 2015; 22: 219–27.
32. Tseng YH, Kokkotou E, Schulz TJ et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008; 454: 1000–4.
33. Elsen M, Raschke S, Tennagels N et al. BMP4 and BMP7 induce the white-to-brown transition of primary human adipose stem cells. Am J Physiol Cell Physiol 2014; 306: C431–40.
34. Bluher M, Mantzoros CS. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism 2015; 64: 131–45.
35. Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012; 55: 2319–26.
36. Yore MM, Syed I, Moraes-Vieira PM et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 2014; 159: 318–32.
37. Awazawa M, Ueki K, Inabe K et al. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 2011; 13: 401–12.
38. Gao H, Fall T, van Dam RM et al. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes 2013; 62: 1338–44.
39. Yaghootkar H, Lamina C, Scott RA et al. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes 2013; 62: 3589–98.
40. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356–62.
41. Abel ED, Peroni O, Kim JK et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 2001; 409: 729–33.
42. Moraes-Vieira PM, Yore MM, Dwyer PM, Syed I, Aryal P, Kahn BB. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab 2014; 19: 512–26.
43. Norseen J, Hosooka T, Hammarstedt A et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol 2012; 32: 2010–9.
44. Qi Q, Yu Z, Ye X et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007; 92: 4827–34.
45. Meisinger C, Ruckert IM, Rathmann W et al. Retinol-binding protein 4 is associated with prediabetes in adults from the general population: the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes Care 2011; 34: 1648–50.
46. van Hoek M, Dehghan A, Zillikens MC, Hofman A, Witteman JC, Sijbrands EJ. An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia 2008; 51: 1423–8.
47. Shepherd PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J Biol Chem 1993; 268: 22243–6.
48. Carvalho E, Kotani K, Peroni OD, Kahn BB. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 2005; 289: E551–61.
49. Boren J, Taskinen MR, Olofsson SO, Levin M. Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 2013; 274: 25–40.
50. Hara T, Kimura I, Inoue D, Ichimura A, Hirasawa A. Free fatty acid receptors and their role in regulation of energy metabolism. Rev Physiol Biochem Pharmacol 2013; 164: 77–116.
51. Oh DY, Talukdar S, Bae EJ et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142: 687–98.
52. Muoio DM, Newgard CB. Diabetes: the good in fat. Nature 2014; 516: 49–50.
53. Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U. Insulin resistance and impaired adipogenesis. Trends Endocrinol. Metab 2015; 26: 193–200.